MedTrace Logo

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

NCT02872987 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-12-05

No results posted yet for this study

Summary

The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.

Conditions

Sponsors & Collaborators

  • Goethe University

    lead OTHER

Principal Investigators

  • Nicola Gökbuget, Dr. med. · University Hospital of Frankfurt (Main)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2030-12-31
Completion
2035-12-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02872987 on ClinicalTrials.gov